cbdMD Inc (YCBD) USD0.001

Sell:$0.59Buy:$0.59$0.01 (2.18%)

Prices delayed by at least 15 minutes
Sell:$0.59
Buy:$0.59
Change:$0.01 (2.18%)
Prices delayed by at least 15 minutes
Sell:$0.59
Buy:$0.59
Change:$0.01 (2.18%)
Prices delayed by at least 15 minutes

Company Information

About this company

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

Key people

T. Ronan Kennedy
Chief Executive Officer, Chief Financial Officer, Director
Bradley Whitford
Chief Accounting Officer, Treasurer, Company Secretary
Sibyl Swift
Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director
Scott G. Stephen
Independent Chairman of the Board
William F. Raines
Independent Director
Bakari T. Sellers
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US12482W3097
  • Market cap
    $3.82m
  • Employees
    42
  • Shares in issue
    6.26m
  • Exchange
    Nyse American LLC
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.